CERT Inflammatory Bowel Disease Study Estimating the Prevalence of Inflammatory Bowel Disease (IBD) and Variation in Prevalence and Health Care Utilization for IBD Among Ten Geographically Managed Care Organizations
Division of Research Principal Investigator: Lisa Herrinton, PhD
Primary Source of Funding: Crohn's and Colitis Foundation of America
Description: This study will provide information on the prevalence and utilization of IBD in 10 HMOs across the country.
Citalopram vs. Placebo for Irritable Bowel Syndrome: Recruitment Plan for KPNC (or “Effect of the Selective Serotonin-Reuptake Inhibitor Citalopram on Clinical Symptoms, Disease-Related Quality of Life and Visceral Sensitivity in Patients with Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial”)
Division of Research Principal Investigator: T.R. Levin, MD
Primary Source of Funding: American Gastroenterological Association
Description: The major goal of this project is to find out if citalopram is superior to placebo in the treatment of Irritable Bowel Syndrome (IBS).
Epidemiology and Incidence of Barrett's Esophagus
Division of Research Principal Investigator: Doug Corley MD, MPH
Primary Source of Funding: National Institute of Diabetes and Digestive and Kidney Diseases
Description: This study is an evaluation of Barrett's esophagus incidence and evaluation of obesity, and several other potential risk factors
Etiologies/Surveillance of Barrett’s Esophagus
Division of Research Principal Investigator: Doug Corley MD, MPH
Primary Source of Funding: National Institute of Diabetes and Digestive and Kidney Diseases
Description: This study evaluates the association between endoscopic surveillance of Barrett’s esophagus and survival, and pharmacologic risk factors for Barrett’s esophagus.
Estimating the Incidence and Prevalence of Inflammatory Bowel Disease (IBD) and Variation in Revalence and Health Care Utilization for IBD among Ten Geographically Diverse Managed Care Organizations
Division of Research Principal Investigator: Lisa Herrinton, PhD
Primary Source of Funding: Crohn’s and Colitis Foundation
Description: Title Describes Study.
Inflammatory Bowel Disease Registry
Division of Research Principal Investigator: T.R. Levin, MD
Primary Source of Funding: Kaiser Permanente Community Benefit Program
Description: This study aims to build a registry of KP members with inflammatory bowel disease (Crohn's disease and Ulcerative Colitis), based on outpatient and inpatient diagnoses and to study resource use and treatment patterns over time.
Natural History of Ulcerative Colitis Following Initial Hospitalization
Division of Research Principal Investigator: Lisa Herrinton, PhD
Primary Source of Funding: NAFSA: Association of International Educators
Population Based Study of IBD Incidence and Prevelance by Disease Subtype and Severity
Division of Research Principal Investigator: Lisa Herrinton, PhD
Primary Source of Funding: Crohn’s and Colitis Foundation
Description: The project seeks to estimate the incidence and prevelance of IBD by disease sybtypae and severity using our existing population-based IBD registry assembled from computerized data.
Retrospective Cohort Pilot Study of Potential Hepatotoxicity of Lovastatin in the Kaiser Permanente Population (aka “Safety of Statins in Patients with Liver Disease”)
Division of Research Principal Investigator: T.R. Levin, MD
Primary Source of Funding: Merck & Company, Inc.
Description: The goal of this study is to evaluate the safety of Lovastatin and other statin medications in patients with minor elevations of liver tests.
Sentinel Surveillance for Chronic Liver Disease
Division of Research Principal Investigator: M. Michele Manos, PhD, MPH
Primary Sources of Funding: Centers for Disease Control and Prevention
Description: The Kaiser Permanente Alameda County Liver Disease Study (a collaborative study with the Centers for Disease Control and Prevention) sought to identify and describe the incidence of newly diagnosed cases of chronic liver disease (CLD) in a defined population. Medical information, research laboratory, and interview information were utilized to estimate the relative proportions of disease that6 are attributable to specific etiologies such as viral infection, alcohol, hepatotoxic drugs, and iron disorders. Risk factors for disease, and potential modifiers of disease progression were also evaluated. Incident cases of CLD were enrolled in the Alameda County Liver Study beginning with the index year 12/1998 through index year 6/2001.
Targeting Delivery and Improving Use of iFOBT
Division of Research Principal Investigator: T.R. Levin, MD
Primary Source of Funding: Enterix Inc
Description: The purpose of this study is to evaluate the feasibility of a direct mailed strategy of immunochemical fecal occult blood testing among Kaiser Permanente, Northern California members aged 60-75.
DOR Administrative Offices
2000 Broadway
Oakland, CA 94612
DOR Clinics
3505 Broadway
Oakland, CA 94611
(510) 891 - 3400
